Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
- PMID: 33469074
- PMCID: PMC7815762
- DOI: 10.1038/s41598-021-81053-6
Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
Abstract
Patients with complicated parapneumonic effusion (CPPE)/empyema have high morbidity and mortality, particularly when adequate management is delayed. We aimed to investigate novel dysregulated cytokines that can be used as biomarkers for infectious pleural effusions, especially for CPPE/empyema. Expression of 40 cytokines in parapneumonic effusions (PPE) was screened in the discovery phase, involving 63 patients, using a multiplex immunobead-based assay. Six cytokines were subsequently validated by enzyme-linked immunosorbent assays (ELISAs). We then used ELISA to further evaluate the diagnostic values and cutoff values of these cytokines as potential biomarkers in an expanded group that included 200 patients with uncomplicated parapneumonic effusion (UPPE), CPPE, empyema, transudates, other exudates, and malignant pleural effusion (MPE). The pleural levels of four cytokines (MIF, MIP-3α, IL-1β, ENA-78) were highest and significantly increased in CPPE/empyema compared with those in other etiologies. According to receiver operating characteristic curve analysis, the four cytokines (MIF, MIP-3α, IL-1β, and ENA-78) had areas under the curve (AUCs) greater than 0.710 for discriminating parapneumonic pleural effusion from noninfectious pleural effusions. In a comparison of nonpurulent CPPE with UPPE, logistic regression analysis revealed that pleural fluid MIF ≥ 12 ng/ml and MIP-3α ≥ 4.3 ng/ml had the best diagnostic value; MIF also displayed the highest odds ratio of 663 for nonpurulent CPPE, with 97.5% specificity, 94.44% sensitivity, and an AUC of 0.950. In conclusion, our results show that elevated MIF and MIP-3α may be used as novel biomarkers for PPE diagnosis, particularly in patients with CPPE/empyema; the findings indicate that dysregulated cytokine expression may provide clues about the pathogenesis of pleural infection.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.Lung. 2006 May-Jun;184(3):141-5. doi: 10.1007/s00408-005-2573-0. Lung. 2006. PMID: 16902838
-
Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.BMC Pulm Med. 2019 Jun 18;19(1):108. doi: 10.1186/s12890-019-0877-8. BMC Pulm Med. 2019. PMID: 31215423 Free PMC article.
-
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.PLoS One. 2015 Jun 15;10(6):e0130141. doi: 10.1371/journal.pone.0130141. eCollection 2015. PLoS One. 2015. PMID: 26076488 Free PMC article.
-
Pleural fluid tests to identify complicated parapneumonic effusions.Curr Opin Pulm Med. 2010 Jul;16(4):357-61. doi: 10.1097/MCP.0b013e328338a108. Curr Opin Pulm Med. 2010. PMID: 20224408 Review.
-
[From pneumonic infiltration to parapneumonic effusion--from effusion to pleural empyema: internal medicine aspects of parapneumonic effusion development and pleural empyema].Wien Med Wochenschr. 2003;153(15-16):349-53. doi: 10.1007/s10354-003-0008-1. Wien Med Wochenschr. 2003. PMID: 13677257 Review. German.
Cited by
-
Immunological characterization of pleural effusions in pediatric patients.Front Immunol. 2024 Dec 16;15:1506073. doi: 10.3389/fimmu.2024.1506073. eCollection 2024. Front Immunol. 2024. PMID: 39737183 Free PMC article.
-
Infective Pleural Effusions-A Comprehensive Narrative Review Article.Clin Pract. 2024 May 16;14(3):870-881. doi: 10.3390/clinpract14030068. Clin Pract. 2024. PMID: 38804400 Free PMC article. Review.
-
Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema.Pharmaceutics. 2023 May 14;15(5):1498. doi: 10.3390/pharmaceutics15051498. Pharmaceutics. 2023. PMID: 37242740 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous